Things are looking bright for Philips Lumileds after an administrative law judge of the US International Trade Commission awarded it a favorable ruling in its current patent litigation against Taiwanese company Epistar Corp.
As India weighs the introduction of a data exclusivity clause into its patent laws, intellectual property experts in the country and around the globe remain fiercely divided over whether such a move would fuel investment or unfairly benefit multinational drug makers.
The U.S. Court of Appeals for the Federal Circuit on Wednesday rejected a request to review an earlier ruling that reinstated a long-running patent dispute between Tyco Healthcare Group LP and Medrad Inc.
Digital camera makers Kodak and Sony have agreed to lay down their swords with a cross-licensing deal that ends a long-running intellectual property fight.
Legislators returning to Capitol Hill for the 110th Congress will have a full menu of proposed intellectual property bills to tackle over the next year, including the evergreen Patent Reform Act and a revamped bill to overhaul the Copyright Act.
Thailand faces a barrage of criticism from drug manufacturers after deciding earlier this month to issue a compulsory license for a generic version of HIV/AIDS drug Sustiva.
U.S. regulators have accepted Roche Holding AG’s Biologic License Application for its hotly litigated anti-anemia drug Mircera, but will extend their review for another three months to review extra data submitted by the company.
Broadcom Corp. scored one victory in the ongoing war between it and rival cell phone chip manufacturer Qualcomm Inc., after the U.S. International Trade Commission decided on Friday to uphold an earlier determination that Qualcomm had infringed on one of Broadcom’s patents.
In the latest development in a legal battle between chip makers Broadcom Corp. and Microtune Inc., the U.S. Patent and Trademark Office has confirmed one of Microtune’s patents after reexamining it at Broadcom’s request.
Free-trade talks between the United States and South Korea came to a standstill on Wednesday when discussions over U.S. anti-dumping laws allegedly unfairly applied to South Korean products were suspended, according to Korean negotiators.
Going over the heads of big pharmaceutical companies, Thailand has issued the first compulsory license for a generic version of Merck & Co Inc.’s HIV-AIDS drug Efavirenz in an effort to lower costs.
Lockheed Martin Corp. and Boeing Co. have finished the merger of their rocket launch businesses, following the U.S. Federal Trade Commission finding in October that national security concerns were more important than the anti-competitive effects of the deal.
Microsoft Corp. and Belkin Corp. have settled a patent infringement suit over so-called U2, or “plug-and-play,” technology, bringing the four-month dispute before the U.S. International Trade Commission to an end.
The United States’ “overprotective patent system” has contributed to decreased competition among technology companies and has helped to stifle creativity and innovation, according to a new report.
Japan’s Seiko Epson Corp. has resolved patent infringement suits with six of 24 defendants in an international dispute over its U.S. ink cartridges.
Broadcom Corp. is looking to compel Kyocera Wireless Corp. to testify in regards to a patent infringement suit it filed against rival cell phone maker Qualcomm Inc.
Under pressure from Bavarian Nordic, the U.S. International Trade Commission has agreed to review an earlier ruling that favored biopharmaceutical rival Acambis in a patent infringement spat over a smallpox vaccine.
Locked in a battle over MP3 player technology, Chinese chip designer Actions Semiconductor Co. Ltd. has asked the U.S. Patent and Trademark Office to reexamine certain patents that are at the center of its infringement dispute with SigmaTel Inc.
Joseph Gioconda has joined DLA Piper US LLC in its New York office, adding his ten years of intellectual property law and trademark infringement experience to the firm’s comprehensive IP practice area.
Pfizer Inc., fresh off a win that validated its Viagra patent in China, has reportedly used its newfound capital to sue a Chinese pharmaceutical company for infringing its patent on the erectile dysfunction drug.